Related Experiment Videos
Gleason's histologic grading as clinical prognostic marker in patients with advanced prostatic carcinoma
C B Schwartz1, H Bekirov, A Melman
1Department of Urology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York.
Urology
|March 1, 1991
Abstract:
We have found that the Gleason's histologic grading system is a good clinical marker to predict long-term response and prognosis in symptomatic Stage D-2 adenocarcinoma of the prostate. In this retrospective study, 56 cases were reviewed and correlated with bone scan, acid phosphatase, and symptomatology following bilateral orchiectomy.